Back to Supplement Score

Supplements for immune support

A small evidence-based set actually does something. The "immune support" supplement aisle is among the most marketed — and most over-promised. Separating signal from advertising matters.

Two truths about immune supplements: (1) the biggest predictors of infection resistance are non-supplement — sleep, exercise, stress, smoking status, body composition, vaccination history. (2) Within the supplement space, only a small group has trial evidence for measurably reducing infection frequency, duration, or severity in immunocompetent adults — vitamin D (in users with deficiency), zinc lozenges (cold duration, within 24h of onset), and selectively elderberry (cold/flu duration). The rest of the "immune boost" aisle is largely marketing — multi-herb formulas without standardised actives, "immunity gummies" with cosmetic micronutrient doses, and "10-billion CFU multi-strain immune probiotics" without strain-specific evidence.
88
Vitamin D3
Reduces ARI in deficient users · Test and correct
Tier 1
82
Zinc acetate / gluconate lozenges
Cold duration ↓33% if started in first 24h · Short-term use
Tier 1
82
Vitamin C (regular use)
Modest cold duration ↓ with regular use · Bigger effect in athletes/stressed
Tier 1
73
Elderberry (Sambucus nigra)
Cold/flu duration · Small trials · Started within 24–48h
Tier 2
76
Probiotics (specific strains)
Modest URI reduction · Strain-specific · Daily preventive
Tier 2
73
Glutamine (for high-load athletes)
URI in endurance athletes · Limited adult value otherwise
Tier 2
76
Beta-glucan (1,3/1,6)
Innate immune activation · Modest URI reduction signal
Tier 2
76
Lactoferrin
Innate immune protein · Small infection signal
Tier 2

The evidence-based immune stack — rationale by ingredient

Vitamin D3 1,000–2,000 IU/day (test and correct)

The Martineau 2017 meta-analysis (BMJ) of 25 RCTs (n=10,933) showed vitamin D supplementation reduced acute respiratory infection incidence, with the largest effect in users with baseline 25-OH-D <25 nmol/L (severe deficiency). Daily/weekly dosing outperformed bolus dosing. Test 25-OH-D and correct to 30–50 ng/mL.

Zinc lozenges at first sniffle (within 24h)

Zinc acetate or gluconate lozenges (13–18 mg elemental zinc per lozenge), dissolved every 2–3 hours while awake for up to 5 days, started within 24h of symptom onset, reduce cold duration by ~33% in meta-analysis. Total daily dose 75–100 mg elemental zinc — high but short-term. Don't use chronically >40 mg/day (copper deficiency risk). See elderberry vs zinc for colds.

Vitamin C 200–500 mg/day regularly + higher during cold

Hemilä 2013 Cochrane review: regular vitamin C supplementation modestly reduces cold duration (~8% in adults, ~14% in children), with larger effects in users under physical stress (marathon runners, soldiers). Doesn't prevent colds in general population. Reasonable inexpensive baseline.

Elderberry standardised extract for cold/flu duration

Small but consistent trial evidence for 2–4 day reduction in cold/flu duration when started within 48 hours of symptoms. Standardised commercial preparations (Sambucol-type). Avoid raw uncooked elderberry. See elderberry vs zinc comparison.

Specific probiotic strains for URI prevention

L. casei DN-114001 (in Actimel/DanActive), L. rhamnosus GG, B. lactis HN019, B. bifidum MIMBb75, and several others have small RCT evidence for reducing upper respiratory infection frequency or duration. Strain identity matters; generic "immune probiotic" formulas are not equivalent.

Glutamine for high-load endurance athletes

Endurance athletes have transient post-exercise immune suppression with elevated URI risk. Glutamine supplementation has small evidence for reducing URI in this specific population. Limited value in the general adult population.

Beta-glucan and lactoferrin — smaller adjunct evidence

Beta-glucan 1,3/1,6 (from yeast cell wall) has modest evidence for reducing URI in stressed populations. Lactoferrin has small evidence for reducing infection in infants and elderly. Both are reasonable adjuncts with niche evidence rather than first-line.

What to skip

Educational reference, not medical advice. Vaccination — annual influenza, COVID-19 updates per local guidance, pneumococcal vaccines at appropriate age/risk, shingles, pertussis — is the single highest-leverage intervention for infection prevention in adults. No supplement substitutes for vaccination. Recurrent or severe infections, particularly with unusual organisms or atypical presentations, warrant medical evaluation for underlying immunodeficiency or other contributing conditions.

Sources

  1. Martineau AR, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017;356:i6583. PMID: 28202713
  2. Hemilä H, Chalker E. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev. 2013;(1):CD000980. PMID: 23440782
  3. Singh M, Das RR. Zinc for the common cold. Cochrane Database Syst Rev. 2013;(6):CD001364. PMID: 23775705
  4. Hawkins J, et al. Black elderberry (Sambucus nigra) supplementation effectively treats upper respiratory symptoms: a meta-analysis of randomized, controlled clinical trials. Complement Ther Med. 2019;42:361–365. PMID: 30670267
  5. King S, et al. Effectiveness of probiotics on the duration of illness in healthy children and adults who develop common acute respiratory infectious conditions: a systematic review and meta-analysis. Br J Nutr. 2014;112(1):41–54. PMID: 24780623
  6. Karsch-Völk M, et al. Echinacea for preventing and treating the common cold. Cochrane Database Syst Rev. 2014;(2):CD000530. PMID: 24554461
  7. Hojsak I, et al. Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics. 2010;125(5):e1171–e1177. PMID: 20403938
See also: Elderberry vs zinc for colds · Allergic rhinitis protocol · Supplements for kids · About